Improving treatment for chronic lymphocytic leukemia by rational use of monoclonal antibodies

Leuk Lymphoma. 2012 Nov;53(11):2101-2. doi: 10.3109/10428194.2012.720980. Epub 2012 Sep 3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Alemtuzumab
  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Antineoplastic Agents / therapeutic use*
  • Complement Activation*
  • Complement System Proteins / immunology*
  • Cytotoxicity, Immunologic / drug effects*
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Male

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Alemtuzumab
  • Complement System Proteins
  • ofatumumab